Healius Limited HLS.AX Stock
Healius Limited Price Chart
Healius Limited HLS.AX Financial and Trading Overview
| Healius Limited stock price | 1.21 AUD |
| Previous Close | 3.15 AUD |
| Open | 3.18 AUD |
| Bid | 3.11 AUD x 0 |
| Ask | 3.12 AUD x 0 |
| Day's Range | 3.11 - 3.22 AUD |
| 52 Week Range | 2.56 - 4.08 AUD |
| Volume | 2.32M AUD |
| Avg. Volume | 1.8M AUD |
| Market Cap | 1.77B AUD |
| Beta (5Y Monthly) | 0.929118 |
| PE Ratio (TTM) | 62.199997 |
| EPS (TTM) | -1.65 AUD |
| Forward Dividend & Yield | 0.12 (3.75%) |
| Ex-Dividend Date | September 7, 2022 |
| 1y Target Est | 3.11 AUD |
HLS.AX Valuation Measures
| Enterprise Value | 3.54B AUD |
| Trailing P/E | 62.199997 |
| Forward P/E | 25.916666 |
| PEG Ratio (5 yr expected) | -1.61 |
| Price/Sales (ttm) | 0.9387509 |
| Price/Book (mrq) | 0.96076614 |
| Enterprise Value/Revenue | 1.874 |
| Enterprise Value/EBITDA | 18.12 |
Trading Information
Healius Limited Stock Price History
| Beta (5Y Monthly) | 0.929118 |
| 52-Week Change | -13.46% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.08 AUD |
| 52 Week Low | 2.56 AUD |
| 50-Day Moving Average | 3.11 AUD |
| 200-Day Moving Average | 3.14 AUD |
HLS.AX Share Statistics
| Avg. Volume (3 month) | 1.8M AUD |
| Avg. Daily Volume (10-Days) | 1.23M AUD |
| Shares Outstanding | 569.53M |
| Float | 517.14M |
| Short Ratio | N/A |
| % Held by Insiders | 1.61% |
| % Held by Institutions | 83.51% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.06 |
| Trailing Annual Dividend Yield | 1.90% |
| 5 Year Average Dividend Yield | 298.00% |
| Payout Ratio | 3.2829 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 2.43% |
| Operating Margin (ttm) | 8.30% |
| Gross Margin | 34.29% |
| EBITDA Margin | 10.33% |
Management Effectiveness
| Return on Assets (ttm) | 2.45% |
| Return on Equity (ttm) | 1.91% |
Income Statement
| Revenue (ttm) | 1.89B AUD |
| Revenue Per Share (ttm) | 3.28 AUD |
| Quarterly Revenue Growth (yoy) | -34.20% |
| Gross Profit (ttm) | 1B AUD |
| EBITDA | 195.1M AUD |
| Net Income Avi to Common (ttm) | 36.2M AUD |
| Diluted EPS (ttm) | 0.05 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 76.1M AUD |
| Total Cash Per Share (mrq) | 0.13 AUD |
| Total Debt (mrq) | 1.79B AUD |
| Total Debt/Equity (mrq) | 97.05 AUD |
| Current Ratio (mrq) | 0.744 |
| Book Value Per Share (mrq) | 3.237 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 407.1M AUD |
| Levered Free Cash Flow (ttm) | 168.28M AUD |
Profile of Healius Limited
| Country | Australia |
| State | NSW |
| City | Sydney |
| Address | Liberty Place |
| ZIP | 2000 |
| Phone | 61 2 9432 9400 |
| Website | https://www.healius.com.au |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 11000 |
Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through four segments: Pathology, Imaging, Day Hospitals, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands. It operates 2,105 pathology sites; 11 day hospital sites; and 134 imaging sites. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
Q&A For Healius Limited Stock
What is a current HLS.AX stock price?
Healius Limited HLS.AX stock price today per share is 1.21 AUD.
How to purchase Healius Limited stock?
You can buy HLS.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Healius Limited?
The stock symbol or ticker of Healius Limited is HLS.AX.
Which industry does the Healius Limited company belong to?
The Healius Limited industry is Diagnostics & Research.
How many shares does Healius Limited have in circulation?
The max supply of Healius Limited shares is 726.1M.
What is Healius Limited Price to Earnings Ratio (PE Ratio)?
Healius Limited PE Ratio is now.
What was Healius Limited earnings per share over the trailing 12 months (TTM)?
Healius Limited EPS is -1.65 AUD over the trailing 12 months.
Which sector does the Healius Limited company belong to?
The Healius Limited sector is Healthcare.
Healius Limited HLS.AX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| S&P/ASX ALL AUSTRALIAN 200 AXAT | 7776.9 AUD 5147.2 USD |
-0.37
|
— — | 7753.3 AUD 5131.58 USD | 7806.8 AUD 5166.99 USD | — - | — — |
| S&P/ASX SMALL ORDINARIES AXSO | 3055.7 AUD 2022.44 USD |
-0.94
|
— — | 3042.1 AUD 2013.44 USD | 3084.6 AUD 2041.56 USD | — - | — — |
| S&P/ASX 300 AXKO | 7711.3 AUD 5103.78 USD |
-0.4
|
— — | 7688.2 AUD 5088.49 USD | 7743.1 AUD 5124.83 USD | — - | — — |
| S&P/ASX 200 EQUAL WEIGHT AXEW | 1883.5 AUD 1246.61 USD |
-0.78
|
— — | 1876.4 AUD 1241.91 USD | 1898.4 AUD 1256.47 USD | — - | — — |
| ALL ORDINARIES AORD | 8014.4 AUD 5304.39 USD |
-0.44
|
— — | 7991.2 AUD 5289.03 USD | 8050.6 AUD 5328.35 USD | — - | — — |
| NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
| S&P/ASX 200 Net Total Rtn AXNT | 93030.3 AUD 61572.77 USD |
-0.38
|
— — | 92750.3 AUD 61387.45 USD | 93395.1 AUD 61814.22 USD | — - | — — |
| S&P/ASX 200 AXJO | 7758.6 AUD 5135.09 USD |
-0.38
|
— — | 7735.2 AUD 5119.6 USD | 7788.9 AUD 5155.14 USD | — - | — — |
- {{ link.label }} {{link}}